Increased to 37 sites
https://www.clinicaltrials.gov/study/NCT06325566?cond=pain&term=mesoblast&rank=3
- Forums
- ASX - By Stock
- Back Pain trial - site increase
MSB
mesoblast limited
Add to My Watchlist
2.16%
!
$2.37

Increased to 37 sites...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.37 |
Change
0.050(2.16%) |
Mkt cap ! $3.020B |
Open | High | Low | Value | Volume |
$2.34 | $2.37 | $2.30 | $5.145M | 2.194M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 5563 | $2.35 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.37 | 24003 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 26077 | 2.350 |
9 | 90286 | 2.340 |
8 | 39113 | 2.330 |
7 | 143810 | 2.320 |
4 | 63080 | 2.310 |
Price($) | Vol. | No. |
---|---|---|
2.370 | 62043 | 4 |
2.380 | 95318 | 9 |
2.390 | 22967 | 4 |
2.400 | 87492 | 10 |
2.410 | 37539 | 3 |
Last trade - 16.19pm 21/08/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, MD & CEO
Michael Thurn
MD & CEO
SPONSORED BY The Market Online